Two Seas Capital LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001823138

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 12 positions · Total reported value $471.58M · Top-10 concentration 99.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 44.2% · 4 new · 11 cut · 4 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 99.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.5% · vs SPY -3.6% · Prev Value $4.17B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.0% · vs SPY -3.1% · Latest Value $7.69B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Two Seas Capital LP disclosed 12 equity positions with a combined reported value of $471.58M. The filing implies a focused portfolio: its ten largest positions account for 99.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were INDV ($315.37M), ROIV ($92.45M), ABUS ($16.81M). By sector, the heaviest allocations are Health Care 93.5%, Technology 2.3%.

Versus the prior quarter, Two Seas Capital LP opened 4 new positions, trimmed 11 and fully exited 4, a turnover rate of 44.2% of positions.

The largest new positions opened in Q3 2023 were INDV ($315.37M), ROIV ($92.45M), ABUS ($16.81M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • INDV INDIVIOR PHARMACEUTICALS INC · $315.37M
  • ROIV ROIVANT SCIENCES LTD · $92.45M
  • ABUS ARBUTUS BIOPHARMA CORP COM · $16.81M
  • MMM 3M CO · $12.17M
  • META META PLATFORMS INC CL-A · $10.86M
  • ESPR ESPERION THERAPEUTICS INC NE · $7.52M
  • SONO SONOS INC · $5.24M
  • OMEX ODYSSEY MARINE EXPL INC · $5.13M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Two Seas Capital LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Two Seas Capital LP is an SEC-registered 13F filer based in Rye, NY, United States. As of Q3 2026 it reported 39 US equity positions with a combined value of $7.69B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: RYE, NY, United States
  • SEC registration: 801-119993 (status: Approved), registered 2020-12-18
  • Regulatory AUM (Form ADV): $2.82B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 9 hedge funds
  • Website: twoseascap.com

Portfolio Structure

  • 39 positions · $7.69B reported value (Q3 2026)
  • Top 10 holdings = 89.3% of reported value
  • Largest position: QQQ (INVESCO QQQ TR) at 51.9%
  • Average position size: $197.25M

Sector Tilt

  • Health Care 11.2%
  • Energy 3.7%
  • Consumer Discretionary 2.8%
  • (classified holdings cover 24% of value)

Quarterly Activity

  • Q3 2026: 4 new, 15 added, 11 reduced, 4 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 93.5%
Technology 2.3%
Other 1.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 13.67M $315.37M 66.88%
66.88%
New
2 7.92M $92.45M 19.60%
19.60%
New
3 8.28M $16.81M 3.56%
3.56%
New
4 130.00K $12.17M 2.58%
2.58%
New
5 36.17K $10.86M 2.30%
2.30%
New
6 7.67M $7.52M 1.59%
1.59%
New
7 406.17K $5.24M 1.11%
1.11%
New
8 1.37M $5.13M 1.09%
1.09%
New
9 86.60K $3.32M 0.70%
0.70%
New
10 87.19K $1.07M 0.23%
0.23%
New
11 164.81K $875.12K 0.19%
0.19%
New
12 123.49K $755.78K 0.16%
0.16%
New

FAQ

What did Two Seas Capital LP buy in 2023-Q3?

In its 2023-Q3 13F filing, Two Seas Capital LP reported 12 equity positions worth $471.58M in aggregate; its largest disclosed positions were INDV ($315.37M), ROIV ($92.45M), ABUS ($16.81M).

How large is Two Seas Capital LP's portfolio?

Two Seas Capital LP reported $471.58M of long equity holdings across 12 positions as of 2023-Q3. Top-10 holdings account for 99.7% of reported value.

What is Two Seas Capital LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/two-seas-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →